Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




A More Comprehensive Approach to Identifying Patients with Mononucleosis

By LabMedica International staff writers
Posted on 10 May 2016
A new systematic review provides advice for earlier, more accurate diagnosis of patients with infectious mononucleosis to help expedite proper treatment.

Symptoms are of limited value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive but nonspecific. More...
When mono patients present with enlarged tonsils and swollen glands, many physicians assume the issue is strep throat and prescribe antibiotics, completely useless against viral mono. "By overusing antibiotics, we increase resistance of bacteria," said study leader Mark H. Ebell, MD, MS, professor, College of Public Health, University of Georgia (Athens, GA, USA), "We waste money. We sometimes cause very serious adverse effects like allergic reactions or Clostridium difficile infection."

In addition to preventing the prescription of useless antibiotics, Prof. Ebell also wanted this study to inform the prognosis and recommendations given to patients after diagnosis. "I like to help doctors make the best use of their clinical skills, of the questions they ask, of the exam maneuvers they do, so they know what to focus on when they're seeing a patient," he said, "Also, we tend to focus a lot on diagnosis and treatment in medicine, but I think that the importance of making a good prognosis is underappreciated. Patients often ask: When am I going to feel better, doc?" For example, patients shouldn't expect to get out and play contact sports soon, as the virus enlarges the spleen (splenomegaly) and puts it at risk of rupturing.

In the 1990s, when Prof. Ebell first published on mono, "what I was struck by then was how limited the research was,” he said, "So I wanted to revisit that area and see if the research had improved over the past 20 years." Prof. Ebell and colleagues set out to systematically review studies involving the clinical diagnosis of mono. Their goal was to determine how clinicians can best use the presence of signs & symptoms and lab tests for white blood cell (WBC) counts.

Their review relied on articles from PubMed and EMBASE dating from 2015 back to 1966 and 1947, respectively. These articles were narrowed to 11 studies that allowed the researchers to look at effectiveness of physical exams and WBC count analysis in detecting mono in individual patients.

They found that the best predictors of mono were swollen posterior cervical or axillary lymph nodes, fatigue, and enlarged spleen, as well as % of a patient's WBCs that are lymphocytes or atypical lymphocytes. Having over 50% lymphocytes or 10% atypical lymphocytes greatly increased the likelihood of mono.

Prof. Ebell noted that the "literature is still pretty bad" when it comes to analyzing mono, but he plans to work in collaboration with UGA's University Health Center to: examine the accuracy of the Monospot test (a screening test for presence of viral antibodies in blood); evaluate the signs & symptoms of patients; and analyze individual patients’ prognoses over the course of illness.

The report, by Ebell MH et al, was published April 12, 2016, in the Journal of the American Medical Association (JAMA).

Related Links:
University of Georgia


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.